{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-067081","form_type":"8-K","ticker":"MOVE","cik":"0001734750","company_name":"Corvex, Inc.","filed_at":"2023-08-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.041491+00:00","generated_at":"2026-06-11T11:52:22.769134+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Movano Health reports Q2 net loss $7.3M; Evie Ring launch planned before Black Friday 2023","bullets":["Net loss $7.3M ($0.17 per share) vs $6.9M loss ($0.21 per share) in Q2 2022; no revenue.","Cash $14.5M at June 30, 2023, up from $10.8M at year-end 2022; raised $9.2M in public offering.","FDA 510(k) for Evie Ring pulse oximeter under full review; launch expected before Black Friday 2023.","Over 600,000 website visitors YTD and 100,000 sign-ups for Evie Ring updates.","Beta partners include global athletic apparel, major health insurer, and remote patient monitoring company."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-067081","json":"https://secwatch.observer/filing/0001213900-23-067081.json","markdown":"https://secwatch.observer/filing/0001213900-23-067081.md","text":"https://secwatch.observer/filing/0001213900-23-067081.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1734750/000121390023067081/0001213900-23-067081-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1734750/000121390023067081/ea183275-8k_movano.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T11:52:22.769134+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cbe7b426904ad3870d59020d6a20eedb8b992fb9","claim":"Corvex, Inc. reported three months ending June 30, 2023 results: net income $7.3 million, EPS $(0.17) per basic and diluted share.","evidence_excerpt":"Movano Health reported a net loss of $7.3 million and a loss of $(0.17) per basic and diluted share, in the second quarter of 2023","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1734750/000121390023067081/0001213900-23-067081-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three months ending June 30, 2023"},{"label":"Net income","value":"$7.3 million"},{"label":"EPS","value":"$(0.17) per basic and diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}